Talat Imran

Insider Reports History

Reporting-owner location: San Jose, CA
Latest reporting-owner signature: /s/ Talat Imran
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Talat Imran

Form 4 holding Chief Executive Officer, Director

Rani Therapeutics Holdings, Inc.

Security class: Class A Common Stock
Shares / value: 461,808
Estimated value: $351,158
Report date: 27 Sep 2026
Price: $0.7604
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Rani Therapeutics Holdings, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 3,800,000
Estimated value
Report date: 03 Jun 2026
Price
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount

Insider Reports Filed by Talat Imran

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 27 Sep 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Sep 2026, 16:42
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 17 Jul 2026
Transactions: 1
Transaction value: +$25,193
Accepted by SEC: 21 Jul 2026, 18:29
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 03 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jun 2026, 18:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 23 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 May 2025, 17:58
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 27 Dec 2024
Transactions: 7
Transaction value: -$11,300
Accepted by SEC: 21 Jul 2026, 18:25
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 09 Dec 2024
Transactions: 1
Transaction value: +$19,974
Accepted by SEC: 10 Dec 2024, 13:12
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 21 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Mar 2024, 21:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 16 Dec 2023
Transactions: 8
Transaction value: $0
Accepted by SEC: 19 Dec 2023, 16:05
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 06 Dec 2023
Transactions: 1
Transaction value: +$22,700
Accepted by SEC: 07 Dec 2023, 17:18
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 04 Dec 2023
Transactions: 1
Transaction value: +$12,850
Accepted by SEC: 06 Dec 2023, 08:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 29 Nov 2023
Transactions: 1
Transaction value: +$41,000
Accepted by SEC: 01 Dec 2023, 08:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 07 Nov 2023
Transactions: 2
Transaction value: +$9,975
Accepted by SEC: 09 Nov 2023, 16:05
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 27 Mar 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 29 Mar 2023, 20:59
Role: CEO, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 22 Mar 2023
Transactions: 1
Transaction value: -$47,529
Accepted by SEC: 24 Mar 2023, 16:05
Role: CEO, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 22 Mar 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 24 Mar 2022, 21:10
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 03 Feb 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 07 Feb 2022, 20:52
Role: Chief Executive Officer, Director
Next action: Open filing details

4 RANI

Rani Therapeutics Holdings, Inc.

Report period: 09 Sep 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Sep 2021, 20:01
Role: Chief Executive Officer, Director
Next action: Open filing details

3/A RANI

Rani Therapeutics Holdings, Inc.

Report period: 29 Jul 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 02 Aug 2021, 19:27
Role: Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .